Follow
maria trojano
maria trojano
Dipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso, UniversitÓ degli Studi
Verified email at uniba.it
Title
Cited by
Cited by
Year
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
58422018
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
10342005
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
M Andersson, J Alvarez-Cermeno, G Bernardi, I Cogato, P Fredman, ...
Journal of Neurology, Neurosurgery & Psychiatry 57 (8), 897-902, 1994
9241994
The genomic history of southeastern Europe
I Mathieson, S Alpaslan-Roodenberg, C Posth, A SzÚcsÚnyi-Nagy, ...
Nature 555 (7695), 197-203, 2018
6612018
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
5482015
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
4872019
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ...
Annals of neurology 89 (4), 780-789, 2021
4512021
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
4172019
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
RC Hermida, JJ Crespo, M DomÝnguez-Sardi˝a, A Otero, A Moya, ...
European heart journal 41 (48), 4565-4576, 2020
3972020
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
RA Marrie, J Cohen, O Stuve, M Trojano, PS S°rensen, S Reingold, ...
Multiple Sclerosis Journal 21 (3), 263-281, 2015
3952015
The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population
MP Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, MF De Caro, F Patti, ...
Multiple Sclerosis Journal 12 (6), 787-793, 2006
3942006
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
E Millefiorini, C Gasperini, C Pozzilli, F D’andrea, S Bastianello, ...
Journal of neurology 244, 153-159, 1997
3771997
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study
C Solaro, G Brichetto, MP Amato, E Cocco, B Colombo, G D’aleo, ...
Neurology 63 (5), 919-921, 2004
3662004
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3622016
Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica
A Ghezzi, R Bergamaschi, V Martinelli, M Trojano, MR Tola, E Merelli, ...
Journal of neurology 251, 47-52, 2004
3592004
New natural history of interferon‐β–treated relapsing multiple sclerosis
M Trojano, F Pellegrini, A Fuiani, D Paolicelli, V Zipoli, GB Zimatore, ...
Annals of neurology 61 (4), 300-306, 2007
3572007
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
3392015
Cognitive and psychosocial features of childhood and juvenile MS
MP Amato, B Goretti, A Ghezzi, S Lori, V Zipoli, E Portaccio, L Moiola, ...
Neurology 70 (20), 1891-1897, 2008
3132008
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an opená…
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3042018
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
L Ruano, E Portaccio, B Goretti, C Niccolai, M Severo, F Patti, S Cilia, ...
Multiple Sclerosis Journal 23 (9), 1258-1267, 2017
2872017
The system can't perform the operation now. Try again later.
Articles 1–20